APPENDIX C 
policies and procedures, announcements -of certified host-vector 
systems, training courses, workshops, conferences, etc. will be 
coordinated with ORDA. 
III. Division of Research Grants 
ORDA will work with the Associate Director for Scientific Review, 
DRG on procedures for the review of grant applications involving 
recombinant K'JA technology. On request, ORDA will brief executive 
secretaries and study sections on NIH policies and procedures. 
Involvement of DRG in the processing of grant applications is 
discussed in Appendix A. 
IV. Institutes. £irid Divisions 
Institutes and Divisions will be required to report to ORDA on 
all activities involving recombinant DNA technology, including: 
intramural research projects, extramural grants and contracts, 
workshops, training courses, conferences, etc. BIDS will provide 
ORDA with copies of all incoming and outgoing correspondence 
dealing with recombinant DNA activities. Awarding components must 
consult with ORDA prior to issuing Requests for Proposals (RFPs) 
and Requests for Applications (RFAs) likely to result in projects 
utilizing recomibinant DNA technology. Procedures for obtaining 
information on extramural research, and for the processing of 
applications are proposed in Appendix A. Procedures for monitor- 
ing intramural research are proposed in Appendix B. 
ORDA will be a source of information for the Institutes and 
Divisions, and their initial review groups, regarding current NIH 
policies and procedures. ORDA may establish an inter-BID Recom- 
binant DNA Coordinating Committee to facilitate interchange of 
information. Because of the procedures proposed, NIH awarding 
components may wish to consider naming specific staff for liaison 
with ORDA. 
V. Special NIH Relationships 
ORDA will maintain close working relationships with the Director, 
Office of Research Safety, NCI, the Associate Director for En- 
vironmental Health and Safety, DRS and the NIH Biohazards 
Committee, and will coordinate their activities on matters re- 
lating to recombinant ENA technology. The Office of Research 
Safety, NCI will continue to have primary responsibility for 
matters relating to physical containment of recombinant EWA 
materials, and will continue to maintain a register of high con- 
tainment facilities in this country and abroad. However, plans 
Appendix C — 3 
